Читать книгу Veterinary Surgical Oncology - Группа авторов - Страница 163
References
Оглавление1 Aitken, M.L. and A.K. Patnaik. 2000. Comparison of needle‐core (Trucut) biopsy and surgical biopsy for the diagnosis of cutaneous and subcutaneous masses: A prospective study of 51 cases (November 1997–August 1998). J Am Anim Hosp Assoc 36(2):153–157.
2 Alberdein, D., J.S. Munday, C.B. Dyer, et al. 2007. Comparison of the histology and immunohistochemistry of vaccination‐site and non‐vaccination‐site sarcomas from cats in New Zealand. N Z Vet J 55(5):203–207.
3 al‐Sarraf, R., G.N. Mauldin, A.K. Patnaik, et al. 1996. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 10(6):376–378.
4 Alvarez, E., J. Dreyfus, T. Carlson, et al. 2017. Well‐differentiated inflammatory liposarcoma with metastasis in a 6‐y‐old cat. J Vet Diagn Invest 29(6):896–899.
5 Anderson, G.M., A. Dallaire, L.M Miller, et al. 1999. Peripheral nerve sheath tumor of the diaphragm with osseous differentiation in a one‐year‐old dog. J Am Anim Hosp Assoc 35(4):319–322.
6 Aper, R. and D. Smeak. 2003. Complications and outcome after thoracodorsal axial pattern flap reconstruction of forelimb skin defects in 10 dogs, 1989–2001. Vet Surg 32(4):378–384.
7 Avallone, G., P. Helmbold, M. Caniatti, et al. 2007. The spectrum of canine cutaneous perivascular wall tumors: Morphologic, phenotypic and clinical characterization. Vet Pathol 44(5):607–620.
8 Avallone G., P. Boracchi, D. Stefanello, et al. 2014. Canine perivascular wall tumors: High prognostic impact of site, depth, and completeness of margins. Vet Pathol 51(4):713–721.
9 Avallone, G., D. Stefanello, P. Boracchi, et al. 2015. Growth factors and COX2 expression in canine perivascular wall tumors. Vet Pathol 52(6):1034–1040.
10 Bacon, N.J., W.S. Dernell, N. Ehrhart, et al. 2007. Evaluation of primary re‐excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999–2004). J Am Vet Med Assoc 230(4):548–554.
11 Bae, S., M. Milovancev, C. Bartels, et al. 2020. Histologically low‐grade, yet biologically high‐grade, canine cutaneous mast cell tumours: A systematic review and meta‐analysis of individual participant data. Vet Comp Oncol 18(4):580–589.
12 Baez, J.L., M.J. Hendrick, F.S. Shofer, et al. 2004. Liposarcomas in dogs: 56 cases (1989–2000). J Am Vet Med Assoc 224(6):887–891.
13 Baginski, H., G. Davis, and R.P. Bastian. 2014. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001–2010). J Am Anim Hosp Assoc 50(2):89–95.
14 Bagley, R.S., S.J. Wheeler, L. Klopp, et al. 1998. Clinical features of trigeminal nerve‐sheath tumor in 10 dogs. J Am Anim Hosp Assoc 34(1):19–25.
15 Baker‐Gabb, M., G.B. Hunt, and M.P. France. 2003. Soft tissue sarcomas and mast cell tumors in dogs: Clinical behaviour and response to surgery. Aust Vet J 81(12):732–738.
16 Bailey, D.B., K.M. Rassnick, O. Kristal, et al. 2008. Phase I dose escalation of single‐agent vinblastine in dogs. J Vet Intern Med 22(6):1397–1402.
17 Baldi, A. and E.P. Spugnini. 2006. Thoracic haemangiopericytoma in a cat. Vet Rec 159(18):598–600.
18 Banerji, N. and S. Kanjilal. 2006. Somatic alterations of the p53 tumor suppressor gene in vaccine‐associated feline sarcoma. Am J Vet Res 67(10):1766–1772.
19 Barbur, L.A., K.D. Coleman, C.W. Schmiedt, et al. 2015. Description of the anatomy, surgical technique, and outcome of hemipelvectomy in 4 dogs and 5 cats. Vet Surg 44(5):613–626.
20 Barrett, L.E., K. Skorupski, D.C. Brown, et al. 2018. Outcome following treatment of feline gastrointestinal mast cell tumours. Vet Comp Oncol 16:188–193.
21 Dewitt, S.B., W.C. Eward, C.A. Eward, et al. 2016. A novel imaging system distinguishes neoplastic from normal tissue during resection of soft tissue sarcomas and mast cell tumors in dogs. Vet Surg 45:715–722.
22 Beer, P., A. Pozzi, C. Rohrer Bley, et al. 2018. The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine. Vet Comp Oncol 16(2):178–187.
23 Ben‐Amotz, R., G.W. Ellison, M.S. Thompson, et al. 2007. Pericardial lipoma in a geriatric dog with an incidentally discovered thoracic mass. J Small Anim Pract 48(10):596–599.
24 Bergman, P.J. 2007. Canine oral melanoma. Clin Tech Small Anim Pract 22(2):55–60.
25 Bergman, P.J., M.A. Camps‐Palau, J.A. McKnight, et al. 2006. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24(21):4582–4585.
26 Bergman, P.J., J. McKnight, A. Novosad, et al. 2003. Long‐term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial. Clin Cancer Res 9(4):1284–1290.
27 Bergman, P.J., S.J. Withrow, R.C. Straw, et al. 1994. Infiltrative lipoma in dogs: 16 cases (1981–1992). J Am Vet Med Assoc 205(2):322–324.
28 Bergman, N.S., B.K. Urie, A.D. Pardo, et al. 2016. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin‐impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009–2012). J Am Vet Med Assoc 248:1148–1156.
29 Berlato, D., S. Murphy, P. Monti, et al. 2015. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours. Vet Comp Oncol 13(2):143–150.
30 Bernstein, J.A., E.C. Hodgin, H.W. Holloway, et al. 2006. Mohs micrographic surgery: A technique for total margin assessment in veterinary cutaneous oncologic surgery. Vet Comp Oncol 4(3):151–160.
31 Boerkamp K.M., E. Teske, L.R. Boon, et al. 2014. Estimated incidence rate and distribution of tumors in 4,653 cases of archival submissions derived from the Dutch golden retriever population. BMC Vet Res 31(10):34.
32 Book, A.P., J. Fidel, T. Wills, et al. 2011. Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors. Vet Radiol Ultrasound 52(5):548–554.
33 Bookbinder, P.F., M.T. Butt, and H.J. Harvey. 1992. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 200(11):1648–1650.
34 Borges, A.F. 1982. Dog‐ear repair. Plast Reconstr Surg 69(4):707–713.
35 Bostock, D.E. 1979. Prognosis after surgical excision of canine melanomas. Vet Pathol 16(1):32–40.
36 Bostock, D.E. 1986. Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J 142(1):1–19.
37 Bostock, D.E. and M.T. Dye. 1980. Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 17(5):581–588.
38 Böttcher, P., S. Klüter, D. Krastel, et al. 2007. Liposuction–removal of giant lipomas for weight loss in a dog with severe hip osteoarthritis. J Small Anim Pract 48(1):46–48.
39 Brambilla, P.G., P. Roccabianca, C. Locatelli, et al. 2006. Primary cardiac lipoma in a dog. J Vet Intern Med 20(3):691–693.
40 Bray, J. and G. Polton. 2016. Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection‐site sarcoma: Results in 21 cats. Vet Comp Oncol 14(2):147–160.
41 Bray, J.P., G.A. Polton, K.D. McSporran, et al. 2014. Canine soft tissue sarcoma managed in first opinion practice: Outcome in 350 cases. Vet Surg 43(7):774–782.
42 Bray, J.P. 2016. Soft tissue sarcoma in the dog – part 1: A current review. J Small Anim Pract 57(10):510–519.
43 Bregazzi, V.S., S.M. LaRue, E. McNiel, et al. 2001. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine‐associated sarcomas: 25 cases (1995–2000). J Am Vet Med Assoc 218(4):547–550.
44 Brehm, D.M., C.H. Vite, H.S. Steinberg, et al. 1995. A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am Anim Hosp Assoc 31(4):349–359.
45 Brissot, H.N. and E.G. Edery. 2017. Use of indirect lymphography to identify sentinel lymph node in dogs: A pilot study in 30 tumours. Vet Comp Oncol 15(3):740–753.
46 Brocks, B.A., I.J. Neyens, E. Teske, et al. 2008. Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: A randomized, double‐blind, placebo‐controlled study. Vet Surg 37(5):472–478.
47 Bronden, L.B., T. Eriksen, and A.T. Kristensen. 2010. Mast cell tumours and other skin neoplasia in Danish dogs – data from the Danish Veterinary Cancer Registry. Acta Vet Scand 52:6.
48 Brown, N.O., A.K. Patnaik, and E.G. MacEwen. 1985. Canine hemangiosarcoma: Retrospective analysis of 104 cases. J Am Vet Med Assoc 186(1):56–58.
49 Bulakowski, E.J., J.C. Philibert, S. Siegel, et al. 2008. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001–2006). J Am Vet Med Assoc 233(1):122–128.
50 Cahalane, A.K., S. Payne, L.G. Barber, et al. 2004. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994–2002). J Am Vet Med Assoc 225(3):401–408.
51 Camus, M.S., H.L. Priest, J.W. Koehler, et al. 2016. Cytologic criteria for mast cell tumor grading in dogs with evaluation of clinical outcome. Vet Pathol 53(6):1117–1123.
52 Cancedda, S., L. Marconato, V. Meier, et al. 2016. Hyperfractionated radiotherapy for macroscopic canine soft tissue sarcoma: A retrospective study of 50 cases treated with a 5 × 6 GY protocol with or without metronomic chemotherapy. Vet Radiol Ultrasound 57(1):75–83.
53 Cantatore, M., M.G. Renwick, and D.A. Yool. 2013. Combined Z‐plasty and phalangeal fillet for reconstruction of a large carpal defect following ablative oncologic surgery. Vet Comp Orthop Traumatol 26(6):510–514.
54 Cantatore, M., R. Ferrari, P. Boracchi, et al. 2014. Factors influencing wound healing complications after wide excision of injection site sarcomas of the trunk of cats. Vet Surg 43(7):783–790.
55 Carlsten, K.S., C.A. London, S.H. Burnett, et al. 2012. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. J Vet Intern Med 26(1):135–141.
56 Cartagena‐Albertus, J.C., A. Moise, S. Moya‐Garcia, et al. 2019. Presumptive primary intrathoracic mast cell tumours in two dogs. BMC Vet Res 15(1):204.
57 Carwardine, D., E. Friend, M. Toscano, et al. 2014. UK owner preferences for treatment of feline injection site sarcomas. J Small Anim Pract 55(2):84–88.
58 Case, J.B., C.M. MacPhail, and S.J. Withrow. 2012. Anatomic distribution and clinical findings of intermuscular lipomas in 17 dogs (2005–2010). J Am Anim Hosp Assoc 48(4):245–249.
59 Cavalcanti, J.V.J., S.L. Barry, and O.I. Lanz. 2018. Reverse saphenous conduit flap in 19 dogs and 1 cat. J Am Anim Hosp Assoc 54(4):213–218.
60 Chase, D., J. Bray, A. Ide, et al. 2009. Outcome following removal of canine spindle cell tumors in first opinion practice: 104 cases. J Small Anim Pract 50(11):568–574.
61 Chhabra, A., O. Ashikyan, C. Slepicka, et al. 2018. Conventional MR and diffusion‐weighted imaging of musculoskeletal soft tissue malignancy: Correlation with histologic grading. Eur Radiol 29(8):4485–4494.
62 Chi, J.T., D.E. Thrall, C. Jiang, et al. 2011. Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics. Clin Cancer Res 17(8):2549–2560.
63 Chijiwa, K., K. Uchida, and S. Tateyama. 2004. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas. Vet Pathol 41(4):307–318.
64 Chu, M.L., G.M. Hayes, J.G. Henry, et al. 2020. Comparison of lateral surgical margins of up to two centimeters with margins of three centimeters for achieving tumor‐free histologic margins following excision of grade I or II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 256(5):567–572.
65 Chun, R. 2005. Common malignant musculoskeletal neoplasms of dogs and cats. Vet Clin North Am Small Anim Pract 35(5):1155–1167, vi.
66 Ciekot, P.A., B.E. Powers, S.J. Withrow, et al. 1994. Histologically low‐grade, yet biologically high‐grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982–1991). J Am Vet Med Assoc 204(4):610–615.
67 Cohen, M., G.S. Post, and J.C. Wright. 2003. Gastrointestinal leiomyosarcoma in 14 dogs. J Vet Intern Med 17(1):107–110.
68 Cohen, P.R., P.T. Martinelli, K.E. Schulze, et al. 2007. The cuticular purse string suture: A modified purse string suture for the partial closure of round postoperative wounds. Int J Dermatol 46(7):746–753.
69 Cohen, M., J.C. Wright, W.R. Brawner, et al. 2001. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine‐associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 219(11):1582–1589.
70 Connery, N.A. and C.R. Bellenger. 2002. Surgical management of haemangiopericytoma involving the biceps femoris muscle in four dogs. J Small Anim Pract 43(11):497–500.
71 Cooper, M., X. Tsai, and P. Bennett. 2009. Combination CCNU and vinblastine chemotherapy for canine mast cell tumors: 57 cases. Vet Comp Oncol 7(3):196–206.
72 Cooper, B.J. and B.A. Valentine. 2002. Tumors of muscle. In Tumors in Domestic Animals, pp. 319–363. D.J. Meuten, editor. Ames: Iowa State Press.
73 Corino, V.D.A., E. Montin, and A. Messina. 2018. Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions. J Magn Reson Imaging 47(3):829–840.
74 Couto, S.S., S.M. Griffey, P.C. Duarte, et al. 2002. Feline vaccine‐associated fibrosarcoma: Morphologic distinctions. Vet Pathol 39(1):33–41.
75 Cronin, K., R.L. Page, G. Spodnick, et al. 1998. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 39(1):51–56.
76 Cunningham, D.V. and O.T. Skinner. 2020. Determination of the lateral extent of the subcutaneous wound bed in canine cadavers after closure of skin defects to replicate tumor excision. Vet Surg 49(4):728–735.
77 Curran, K.M., C.H. Halsey, and D.R. Worley. 2016. Lymphangiosarcoma in 12 dogs: A case series (1998–2013). Vet Comp Oncol 14(2):181–190.
78 Daly, M.K., C.F. Saba, S.S. Crochik, et al. 2008. Fibrosarcoma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 10(2):202–205.
79 Davidson, E.B., C.R. Gregory, and P.H. Kass. 1997. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 26(4):265–269.
80 Davies, D.R., K.M. Wyatt, J.E. Jardine, et al. 2004. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 40(2):124–130.
81 Davis, K.M., E.M. Hardie, B.D. Lascelles, et al. 2007. Feline fibrosarcoma: Perioperative management. Compend Contin Educ Vet 29(12):712–714.
82 De Queiroz G.F., M.L.Dagli, S.A. Meira et al. 2013. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas. Vet Comp Oncol 11(3):230–235.
83 Dean, R.S., D.U. Pfeiffer, and V.J. Adams. 2013. The incidence of feline injection site sarcomas in the United Kingdom. BMC Vet Res 9:17.
84 Demetriou, J.L., C.J. Shales, and M.H. Hamilton. 2007. Reconstruction of a nonhealing lick granuloma in a dog using a phalangeal fillet technique. J Am Anim Hosp Assoc 43(5):288–291.
85 Demetriou, J.L., M.J. Brearley, F. Constantino‐Casas, et al. 2012. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. J Small Anim Pract 53(3):174–181.
86 Dennis, R. 2008. Imaging features of orbital myxosarcoma in dogs. Vet Radiol Ultrasound 49(3):256–263.
87 Dennis, M.M., K.D. McSporran, N.J. Bacon, et al. 2011. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Vet Pathol 48(1):73–84.
88 Dernell, W.S., S.J. Withrow, C.A. Kuntz, et al. 1998. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13(1):59–64.
89 De Queiroz, G.F., J.M. Matera, and M.L. Zaidan Dagli. 2008. Clinical study of cryosurgery efficacy in the treatment of skin and subcutaneous tumors in dogs and cats. Vet Surg 37(5):438–443.
90 Dillon, C.J., G.N. Mauldin, and K.E. Baer. 2005. Outcome following surgical removal of nonvisceral soft tissue sarcomas in cats: 42 cases (1992–2000). J Am Vet Med Assoc 227(12):1955–1957.
91 Dobromylskyj, M.J., V. Richards, and K.C. Smith. 2021. Prognostic factors and proposed grading system for cutaneous and subcutaneous soft tissue sarcomas in cats, based on a retrospective study. J Feline Med Surg 23:168–174.
92 Dobson, J., S. Cohen, and S. Gould. 2004. Treatment of canine mast cell tumors with prednisolone and radiotherapy. Vet Comp Oncol 2(3):132–141.
93 Dobson, J.M., S. Samuel, H. Milstein, et al. 2002. Canine neoplasia in the UK: Estimates of incidence rates from a population of insured dogs. J Small Anim Pract 43(6):240–246.
94 Donnelly, L., C. Mullin, J. Blako, et al. 2015. Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumours. Vet Comp Oncol 13(1):70–76.
95 Dornbusch, J.A., C. Cocca, R. Jennings, et al. 2020. The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumours. Vet Comp Oncol September 20. doi: 10.1111/vco.12654.
96 Dornbusch, J.A., L.E. Selmic, P.C. Huang, et al. 2021. Diagnostic accuracy of optical coherence tomography for assessing surgical margins of canine soft tissue sarcomas in observers of different specialties. Vet Surg 50:111–120.
97 Eckstein, C., F. Guscetti, M. Roos, et al. 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine‐associated sarcoma. Vet Comp Oncol 7(1):54–68.
98 Ehrhart, N. 2005. Soft‐tissue sarcomas in dogs: A review. J Am Anim Hosp Assoc 41(4):241–246.
99 Elliott, R.C. 2014. Reverse saphenous conduit flap in small animals: Clinical applications and outcomes. J S Afr Vet Assoc 85(1):1038.
100 Elmslie, R.E., P. Glawe, and S.W. Dow. 2008. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 22(6):1373–1379.
101 Endicott, M.M., S.C. Charney, J.A. McKnight, et al. 2007. Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumors: 157 cases (1999–2002). Vet Comp Oncol 5(1):31–37.
102 Enneking, W.F. and G.E. Maale. 1988. The effect of inadvertent tumor contamination of wounds during the surgical resection of musculoskeletal neoplasms. Cancer 62(7):1251–1256.
103 Enneking, W.F., S.S. Spanier, and M.A. Goodman. 1980. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120.
104 Essman, S.C., J.P. Hoover, R.J. Bahr, et al. 2002. An intrathoracic malignant peripheral nerve sheath tumor in a dog. Vet Radiol Ultrasound 43(3):255–259.
105 Ettinger, S.N. 2003. Principles of treatment for soft‐tissue sarcomas in the dog. Clin Tech Small Anim Pract 18(2):118–122.
106 Ettinger, S.N., T.J. Scase, K.T. Oberthaler, et al. 2006. Association of argyrophilic nucleolar organizing regions, Ki‐67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996–2002). J Am Vet Med Assoc 228(7):1053–1062.
107 Field, E.J., G. Kelly, D. Pleuvry, et al. 2015. Indications, outcome and complications with axial pattern skin flaps in dogs and cats: 73 cases. J Small Anim Pract 56(12):698–706.
108 Evans, B. J., D. O’Brien, S.D. Allstadt, et al. 2018. Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi‐institutional retrospective study of 64 cases. Vet Comp Oncol 16(1):20–27.
109 Ferrari, R., L. Marconato, P. Buracco, et al. 2018. The impact of extirpation of non‐palpable/normal‐sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Vet Comp Oncol 16(4):505–510.
110 Finocchiaro, L.M. and G.C. Glikin. 2012. Cytokine‐enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow‐up. Cancer Gene Ther 19(12):852–861.
111 Finocchiaro, L.M., C. Fondello, M.L. Gil‐Cardeza, et al. 2015. Cytokine‐enhanced vaccine and interferon‐β plus suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma. Hum Gene Ther 26(6):367–376.
112 Finora, K., N.F. Leibman, M.J. Fettman, et al. 2006. Cytological comparison of fine‐needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumors and an ultrasonographically normal appearing liver and spleen. Vet Comp Oncol 4(3):178–183.
113 Foale, R.D., R.A. White, R. Harley, et al. 2003. Left ventricular myxosarcoma in a dog. J Small Anim Pract 44(11):503–507.
114 Forrest, L.J., R. Chun, W.M. Adams, et al. 2000. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 14(6):578–582.
115 Fossum, T.W., C.G. Couto, W.D. DeHoff, et al. 1988. Treatment of hemangiopericytoma in a dog, using surgical excision, radiation, and a thoracic pedicle skin graft. J Am Vet Med Assoc 193(11):1440–1442.
116 Fowler, J.D., D.A. Degner, and R. Walshaw. 1998. Microvascular free tissue transfer: Results in 57 consecutive cases. Vet Surg 27(5):406–412.
117 Fournier, Q., P. Cazzini, S. Bavcar, et al. 2018. Investigation of the utility of lymph node fine‐needle aspiration cytology for the staging of malignant solid tumors in dogs. Vet Clin Pathol 47(3):489–500.
118 Fries, L.F., J. Tartaglia, J. Taylor, et al. 1996. Human safety and immunogenicity of a canarypox‐rabies glycoprotein recombinant vaccine: An alternative poxvirus vector system. Vaccine 14(5): 428–434.
119 Frimberger, A.E., A.S. Moore, S.M. LaRue, et al. 1997. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989–1993). J Am Anim Hosp Assoc 33(4):320–324.
120 Fuerst, J.A., J.K. Reichle, D. Szabo, et al. 2017 Computed tomographic findings in 24 dogs with liposarcoma. Vet Radiol Ultrasound 58(1):23–28.
121 Fukumoto, S., T. Miyasho, K. Hanazono, et al. 2015. Big endothelin‐1 as a tumour marker for canine haemangiosarcoma. Vet J 204(3):269–274.
122 Fulcher, R.P., L.L. Ludwig, P.J. Bergman, et al. 2006. Evaluation of a two‐centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 228(2):210–215.
123 Gagnon, J., M.N. Mayer, T. Belosowsky, et al. 2020. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs. J Am Vet Med Assoc 256:102–110.
124 Gaitero, L., S. Anor, D. Fondevila, et al. 2008. Canine cutaneous spindle cell tumors with features of peripheral nerve sheath tumors: A histopathological and immunohistochemical study. J Comp Pathol 139(1):16–23.
125 Galeotti, F., F. Barzagli, A. Vercelli, et al. 2004. Feline lymphangiosarcoma – definitive identification using a lymphatic vascular marker. Vet Dermatol 15(1):13–18.
126 Ghisleni, G., P. Roccabianca, R. Ceruti, et al. 2006. Correlation between fine‐needle aspiration cytology and histopathology in the evaluation of cutaneous and subcutaneous masses from dogs and cats. Vet Clin Pathol 35(1):24–30.
127 Gieger, T.L., A.P. Theon, J.A. Werner, et al. 2003. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990–2001). J Vet Intern Med 17(5):687–692.
128 Gill, V., N.F. Leibman, S. Monette, et al. 2007. Histologic grade, proliferation indices and clinical outcome in canine subcutaneous mast cell tumors. In Proceedings of the 27th Veterinary Cancer Society Annual conference. Fort Lauderdale, FL, November 1–4, 2007.
129 Gill, V., N. Leibman, S. Monette, et al. 2020. Prognostic indicators and clinical outcome in dogs with subcutaneous mast cell tumors treated with surgery alone: 43 cases. J Am Anim Hosp Assoc 56(4):215–225.
130 Gilson, S.D. and E.A. Stone. 1990. Surgically induced tumor seeding in eight dogs and two cats. J Am Vet Med Assoc 196(11):1811–1815.
131 Gobar, G.M. and P.H. Kass. 2002. World Wide Web‐based survey of vaccination practices, postvaccinal reactions, and vaccine site‐associated sarcomas in cats. J Am Vet Med Assoc 220:1477–1482.
132 Goldschmidt, M.H. and M.J. Hendrick. 2002. Tumors of the skin and soft tissues. In Tumors in Domestic Animals. 4th edition, p. 45. D.J. Meuten, editor. Iowa City: Iowa State Press.
133 Goldschmidt, M.H. and F.S. Shofer. 1992. Skin Tumors of the Dog and Cat, 1st edition. M.H. Goldschmidt and F.S. Shofer, editors. Oxford: Pergamon Press.
134 Goldschmidt, M.H. and F.S. Shofer. 1998. Uncommon skin tumors. In Skin Tumors of the Dog and Cat, pp. 291–295. M.H. Goldschmidt and F.S. Shofer, editors. New York: Butterworth Heinemann.
135 Graf, R., A. Pospischil, F. Guscetti, et al. 2018. Cutaneous tumors in Swiss dogs: Retrospective data from the Swiss Canine Cancer Registry, 2008–2013. Vet Pathol 55(6):809–820.
136 Graves, G.M., D.E. Bjorling, and E. Mahaffey. 1988. Canine hemangiopericytoma: 23 cases (1967–1984). J Am Vet Med Assoc 192(1):99–102.
137 Greene, F.L. 2002. AJCC Cancer Staging Manual. American Joint Committee on Cancer, Report No.: 0387952713. New York: American Cancer Society.
138 Grier, R.L., G. Di Guardo, R. Myers, et al. 1995. Mast cell tumor destruction in dogs by hypotonic solution. J Small Anim Pract 36(9):385–388.
139 Grimes, J.A., S.A. Secrest, N.C. Northrup, et al. 2017. Indirect computed tomography lymphangiography with aqueous contrast for evaluation of sentinel lymph nodes in dogs with tumors of the head. Vet Radiol Ultrasound 58(5):559–564.
140 Grimes, J.A., S.A. Secrest, M.L. Wallace, et al. 2020. Use of indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre‐operative diagnosis of melanoma or mast cell tumour. Vet Comp Oncol 18(4):818–824.
141 Gross, T.L., P.J. Ihrke, E.J. Walder, et al. 2005. Skin Diseases of the Dog and Cat: Clinical Histopathologic Diagnosis, 2nd edition. Oxford: Blackwell Science.
142 Gruntzig, K., R. Graf, M. Hassig, et al. 2015. The Swiss Canine Cancer Registry: A retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol 152(2–3):161–171.
143 Grüntzig, K., R. Graf, G. Boo, et al. 2016. Occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex and neutering status on tumour development. Swiss Canine Cancer Registry 1955–2008. J Comp Pathol 155(2–3):156–170.
144 Haagsman, A.N., A.C. Witkamp, B.E. Sjollema, et al. 2013. The effect of interleukin‐2 on canine peripheral nerve sheath tumors after marginal surgical excision: A double‐blind randomized study. BMC Vet Res 9:155.
145 Hahn, K.A., G.K. King, and J.K. Carreras. 2004. Efficacy of radiation therapy for incompletely resected grade‐III mast cell tumors in dogs: 31 cases (1987–1998). J Am Vet Med Assoc 224(1):79–82.
146 Hahn, K.A., M.M. Endicott, G.K. King, et al. 2007. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989–1999). J Am Vet Med Assoc 231(5):742–745.
147 Hahn, K.A., G. Ogilvie, T. Rusk, et al. 2008. Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med 22(6):1301–1309.
148 Hammer, A.S., C.G. Couto, J. Filppi, et al. 1991. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5(3):160–166.
149 Hanna, S.L. and B.D. Fletcher. 1995. MR imaging of malignant soft tissue tumors. Magn Reson Imaging Clin N Am 3(4):629–650.
150 Hansen, K.S., A.L. Zwingenberger, A.P. Théon, et al. 2016. Treatment of MRI‐diagnosed trigeminal peripheral nerve sheath tumors by stereotactic radiotherapy in dogs. J Vet Intern Med 30(4):1112–1120.
151 Harcourt‐Brown, T.R., N. Granger, P.M. Smith, et al. 2009. Use of a lateral surgical approach to the femoral nerve in the management of two primary femoral nerve sheath tumors. Vet Comp Orthop Traumatol 22(3):229–232.
152 Halsey, C.H., D.R. Worley, K. Curran, et al. 2016. The use of novel lymphatic endothelial cell‐specific immunohistochemical markers to differentiate cutaneous angiosarcomas in dogs. Vet Comp Oncol 14(3):236–244.
153 Hargis, A.M., P.J. Ihrke, W.L. Spangler, et al. 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29(4):316–328.
154 Harris, K.P., J.M. Dobson, F. Constantino‐Casas, et al. 2014. Evaluation of the tumor bed biopsy technique in canine and feline oncologic surgery. In 23rd Annual ECVS Scientific Meeting Copenhagen, Denmark, July 3–5, 2014, Published in: Vet Surg 43(5):E125.
155 Hartmann, K., M.J. Day, E. Thiry, et al. 2015. Feline injection‐site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 17(7):606–613.
156 Headley, S.A., A.C. Faria Dos Reis, and A.P. Frederico. 2011. Cutaneous myxosarcoma with pulmonary metastases in a dog. J Comp Pathol 145(1):31–34.
157 Heller, D., M.E. Stebbins, T. Reynolds, et al. 2005. A retrospective study of 87 cases of canine soft tissue sarcoma, 1986–2001. Int J Appl Res Vet Med 3:81–87.
158 Hendrick, M.J. and M.H. Goldschmidt. 1991. Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 199(8):968.
159 Henney, L.H. and M.M. Pavletic. 1988. Axial pattern flap based on the superficial brachial artery in the dog. Vet Surg 17(6):311–317.
160 Hergt, F., W. von Bomhard, M.S. Kent, et al. 2016. Use of a 2‐tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens. Vet Clin Pathol 45(3):477–483.
161 Hershey, A.E., K.U. Sorenmo, M.J. Hendrick, et al. 2000. Prognosis for presumed feline vaccine‐associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216(1):58–61.
162 Hill, J., J. Lawrence, C. Saba, et al. 2014. In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line. Res Vet Sci 97(2):348–356.
163 Hobert, M.K., C. Brauer, P. Dziallas, et al. 2013 Infiltrative lipoma compressing the spinal cord in 2 large‐breed dogs. Can Vet J 54(1):74–78.
164 Horta, R.D.S., A. Giuliano, G.E. Lavalle, et al. 2018. Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high‐risk canine mast cell tumours to tyrosine kinase inhibitors. Oncol Lett 15:129–136.
165 Hosoya, K., W.C. Kisseberth, F.J. Alvarez, et al. 2009. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors. J Am Anim Hosp Assoc 45(1):14–18.
166 Hudson‐Peacock, M.J. and C.M. Lawrence. 1995. Comparison of wound closure by means of dog ear repair and elliptical excision. J Am Acad Dermatol 32(4):627–630.
167 Hughes, J.R., B. Szladovits, and R. Drees. 2019. Abdominal CT evaluation of the liver and spleen for staging mast cell tumors in dogs yields nonspecific results. Vet Radiol Ultrasound 60(3):306–315.
168 Hume, C.T., M. Kiupel, L. Rigatti, et al. 2011. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997–2007). J Am Anim Hosp Assoc 47(1):37–44.
169 Hunt, G.B., J. Wong, and S. Kuan. 2011. Liposuction for removal of lipomas in 20 dogs. J Small Anim Pract 52(8):419–425.
170 Isotani, M., N. Ishida, M. Tominaga, et al. 2008. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. J Vet Intern Med 22(4):985–988.
171 Jaber, O., M. Vischio, A. Faga, et al. 2015. The three‐bite technique: A novel method of dog ear correction. Arch Plast Surg 42(2):223–225.
172 Jackson, D.E., L.M. Berent, L.A. Cohn, et al. 2011. Locally invasive lymphangiosarcoma in a young domestic shorthair. J Feline Med Surg 13(10):796–799.
173 Jaffe, M.H., G. Hosgood, S.C. Kerwin, et al. 2000. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumors. J Small Anim Pract 41(1):7–11.
174 Johannes, C.M., C.J. Henry, S.E. Turnquist, et al. 2007. Hemangiosarcoma in cats: 53 cases (1992–2002). J Am Vet Med Assoc 231(12):1851–1856.
175 Johnson, T.O., F.Y. Schulman, T.P. Lipscomb, et al. 2002. Histopathology and biologic behavior of pleomorphic cutaneous mast cell tumors in fifteen cats. Vet Pathol 39(4):452–457.
176 Jourdier, T.M., C. Moste, M.C. Bonnet, et al. 2003. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10(26):2126–2132.
177 Kaldrymidou, H., L. Leontides, A.F. Koutinas, et al. 2002. Prevalence, distribution and factors associated with the presence and the potential for malignancy of cutaneous neoplasms in 174 dogs admitted to a clinic in northern Greece. J Vet Med A Physiol Pathol Clin Med 49(2):87–91.
178 Kamstock, D., R. Elmslie, D. Thamm, et al. 2007. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Cancer Immunol Immunother 56(8):1299–1309.
179 Kantor, J. 2015. The dog‐ear tacking suture technique. J Am Acad Dermatol 73(1):e25–e26.
180 Kapatkin, A.S., H.S. Mullen, D.T. Matthiesen, et al. 1992. Leiomyosarcoma in dogs: 44 cases (1983–1988). J Am Vet Med Assoc 201(7):1077–1079.
181 Karbe, G.T., E. Davis, J.J. Runge, et al. 2021. Evaluation of scar revision after inadequate primary excision of cutaneous mast cell tumors in 85 dogs (2000–2013). Vet Surg. 50(4):807–815.
182 Kass P.H., W.G. Barnes Jr., W.L. Spangler, et al. 1993. Epidemiological evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 203:396–405.
183 Kass, P.H., W.L. Spangler, M.J. Hendrick, et al. 2003. Multicenter case control study of risk factors associated with development of vaccine‐associated sarcomas in cats. J Am Vet Med Assoc 223(9):1283–1292.
184 Katayama R., M.K. Huelsmayer, A.K. Marr, et al. 2004. Imatinib mesylate inhibits platelet‐derived growth factor activity and increases chemosensitivity in feline vaccine‐associated sarcoma. Cancer Chemother Pharmacol 54: 25–33.
185 Kim, H.J., H.S. Chang, C.B. Choi, et al. 2005. Infiltrative lipoma in cervical bones in a dog. J Vet Med Sci 67(10):1043–1046.
186 Kim, D.Y., D.Y. Cho, D.Y. Kim, et al. 2003. Malignant peripheral nerve sheath tumor with divergent mesenchymal differentiations in a dog. J Vet Diagn Invest 15(2):174–178.
187 Kirby, P.M., J.M. Miller, J.M. Goggin. 2014. What is your diagnosis? Grade 2 myxosarcoma of the subcutis and bone. J Am Vet Med Assoc 245(11):1221–1223.
188 Kirpensteijn, J. and G. Ter Haar. 2013. Reconstructive Surgery and Wound Management of the Dog and Cat. Boca Raton: CRC Press.
189 Kiupel, M., J.D. Webster, J.B. Kaneene, et al. 2004. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41(4):371–377.
190 Kiupel, M., J.D. Webster, R.A. Miller, et al. 2005. Impact of tumor depth, tumor location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumors. J Vet Med A Physiol Pathol Clin Med 52(6):280–286.
191 Kiupel, M., J.D. Webster, K.L. Bailey, et al. 2011. Proposal of a 2‐tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 48(1):147–155.
192 Kliczkowska, K., U. Jankowska, D. Jagielski, et al. Epidemiological and morphological analysis of feline injection site sarcomas. 2015. Pol J Vet Sci 18(2):313–322.
193 Kobayashi, T, M.L. Hauck, R. Dodge, et al. 2002. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 43(5):473–479.
194 Kolm, U.S., M. Kleiter, A. Kosztolich, et al. 2002. Benign intrapericardial lipoma in a dog. J Vet Cardiol 4(1):25–29.
195 Kok, M.K., J.K. Chambers, M. Tsuboi, et al. 2019. Retrospective study of canine cutaneous tumors in Japan, 2008–2017. J Vet Med Sci 81(8):1133–1143.
196 Kotilingam, D., D.C. Lev, A.J. Lazar, et al. 2006. Staging soft tissue sarcoma: Evolution and change. CA Cancer J Clin 56(5):282–291.
197 Kraus, K.A., C.A. Clifford, G.J. Davis, et al. 2015. Outcome and prognostic indicators in cats undergoing splenectomy for splenic mast cell tumors. J Am Anim Hosp Assoc 51(4):231–238.
198 Krick, E.L., A.P. Billings, F.S. Shofer, et al. 2009. Cytological lymph node evaluation in dogs with mast cell tumors: Association with grade and survival. Vet Com Oncol 7(2):130–138.
199 Kristal, O., K.M. Rassnick, J.M. Gliatto, et al. 2004. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 18(1):75–80.
200 Kry, K.L. and S.E. Boston. 2014. Additional local therapy with primary re‐excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs. Vet Surg 43(2):182–189.
201 Ku, C.K., P.H. Kass, and M.M. Christopher. 2017. Cytologic‐histologic concordance in the diagnosis of neoplasia in canine and feline lymph nodes: A retrospective study of 367 cases. Vet Comp Oncol 15(4):1206–1217.
202 Kung, M.B.J., V.J. Poirier, M.M. Dennis, et al. 2016. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma. Vet Comp Oncol 14(4):e135–e145.
203 Kuntz, C.A., W.S. Dernell, B.E. Powers, et al. 1997. Prognostic factors for surgical treatment of soft‐tissue sarcomas in dogs: 75 cases (1986–1996). J Am Vet Med Assoc 211(9):1147–1151.
204 Kurupati, R.K., X. Zhou, Z. Xiang, et al. 2018. Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma. Cancer Immunol Immunother 67(10):1533–1544.
205 Lachowicz, J.L., G.S. Post, and E. Brodsky. 2005. A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor‐bearing cats. J Vet Intern Med 19(6):860–864.
206 LaDouceur, E.E.B., S.E. Stevens, J. Wood, et al. 2017. Immunoreactivity of canine liposarcoma to muscle and brown adipose antigens. Vet Pathol 54(6):885–891.
207 LaDue, T., G.S. Price, R. Dodge, et al. 1998. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 39(1):57–62.
208 Lampreht, U., U. Kamensek, M. Stimac, et al. 2015. Gene electrotransfer of canine interleukin 12 into canine melanoma cell lines. J Membr Biol 248(5):909–917.
209 Tratar, U.L., S. Kos, U. Kamensek, et al. 2018. Antitumor effect of antibiotic resistance gene‐free plasmids encoding interleukin‐12 in canine melanoma model. Cancer Gene Ther 25(9–10):260–273.
210 Langenbach, A., P.M. McManus, M.J. Hendrick, et al. 2001. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. J Am Vet Med Assoc 218(9):1424–1428.
211 Lapsley, J., G.M. Hayes, V. Janvier, et al. 2021. Influence of locoregional lymph node aspiration cytology vs sentinel lymph node mapping and biopsy on disease stage assignment in dogs with integumentary mast cell tumors. Vet Surg 50(1):133–141.
212 Laver, T., B.R. Feldhaeusser, C.S. Robat, et al. 2018. Post‐surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003–2015). Can Vet J 59(9):981–987.
213 Lawrence, J., L. Forrest, W. Adams, et al. 2008. Four‐fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogs. J Am Anim Hosp Assoc 44(3):100–108.
214 LeCouteur, R.A. 2001. Tumors of the nervous system. In Small Animal Clinical Oncology, pp. 381–455. S.J. Withrow and E.G. MacEwen, editors. Philadelphia: WB Saunders.
215 Lee, T.S., C.S. Murakami, and A.C. Suryadevara. 2011. Tissue conservation using circular defect with dog‐ear deformities excision technique. Laryngoscope 121(11):2299–2304.
216 Leiter, U. and C. Garbe. 2008. Epidemiology of melanoma and nonmelanoma skin cancer – The role of sunlight. Adv Exp Med Biol 624:89–103.
217 Lenard, Z.M., S.F. Foster, A.J. Tebb, et al. 2007. Lymphangiosarcoma in two cats. J Feline Med Surg 9(2):161–167.
218 Lepri, E., G. Ricci, L. Leonardi, et al. 2003. Diagnostic and prognostic features of feline cutaneous mast cell tumors: A retrospective analysis of 40 cases. Vet Res Commun 27(Suppl 1):707–709.
219 Levy, M.S., A.S. Kapatkin, A.K. Patnaik, et al. 1997. Spinal tumors in 37 dogs: Clinical outcome and long‐term survival (1987–1994). J Am Anim Hosp Assoc 33(4):307–312.
220 Lidbetter, D.A., F.A. Williams Jr., D.J. Krahwinkel, et al. 2002. Radical lateral body‐wall resection for fibrosarcoma with reconstruction using polypropylene mesh and a caudal superficial epigastric axial pattern flap: A prospective clinical study of the technique and results in 6 cats. Vet Surg 31(1):57–64.
221 Liptak, J.M. 2007. Soft tissue sarcomas. In Withrow & MacEwen’s Small Animal Clinical Oncology, pp. 425–454. S.J. Withrow and E.G. MacEwen, editors. WB Saunders: St. Louis.
222 Liptak, J.M. and L.J. Forrest. 2013. Soft tissue sarcomas. In Withrow & McEwen’s Small Animal Clinical Oncology, 5th edition. S.J. Withrow, D.M. Vail and R.L. Page, editors. St. Louis: Elsevier.
223 Little, L.K. and M. Goldschmidt. 2007. Cytologic appearance of a keloidal fibrosarcoma in a dog. Vet Clin Pathol 36(4):364–367.
224 Litster, A.L. and K.U. Sorenmo. 2006. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia. J Feline Med Surg 8(3):177–183.
225 Liu, S.M. and I. Mikaelian. 2003. Cutaneous smooth muscle tumors in the dog and cat. Vet Pathol 40(6):685–692.
226 Liu, Q.Y., H.G. Li, J.Y. Chen, et al. 2008. Correlation of MRI features to histopathologic grade of soft tissue sarcoma. Ai Zheng 27(8):856–860.
227 London, C.A., P.B. Malpas, S.L. Wood‐Follis, et al. 2009. Multi‐center, placebo‐controlled, double‐blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clin Cancer Res 15(11):3856–3865.
228 Longo, M., S.C. Modina, A. Bellotti, et al. 2015. Advances in the anatomic study of the interscapular region of the cat. BMC Vet Res 11:249.
229 López‐Pousa, A., J. Martin Broto, J. Martinez Trufero, et al. 2016. SEOM clinical guideline of management of soft‐tissue sarcoma. Clin Transl Oncol 18(12):1213–1220.
230 Lowe, R., A. Gavazza, J.A. Impellizeri, et al. 2017. The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision. Vet Comp Oncol 15(3):775–784.
231 Luna, L.D., M.L. Higginbotham, C.J. Henry, et al. 2000. Feline nonocular melanoma: A retrospective study of 23 cases (1991–1999). J Feline Med Surg 2(4):173–181.
232 MacEwen, E.G., I.D. Kurzman, D.M. Vail, et al. 1999. Adjuvant therapy for melanoma in dogs: Results of randomized clinical trials using surgery, liposome‐encapsulated muramyl tripeptide, and granulocyte macrophage colony‐stimulating factor. Clin Cancer Res 5(12):4249–4258.
233 MacEwan, E.G., B.E. Powers, and D. Macy. 2001. Soft tissue sarcomas. In Small Animal Clinical Oncology, 3rd edition. S.J. Withrow, editor. Philadelphia: WB Saunders.
234 Maglennon, G.A., S. Murphy, V. Adams, et al. 2008. Association of Ki67 index with prognosis for intermediate‐grade canine cutaneous mast cell tumors. Vet Comp Oncol 6(4):268–274.
235 Majeski, S.A., M.A. Steffey, M. Fuller, et al. 2017. Indirect computed tomographic lymphography for iliosacral lymphatic mapping in a cohort of dogs with anal sac gland adenocarcinoma: Technique description. Vet Radiol Ultrasound 58(3):295–303.
236 Mandara, M.T., E. Fabriani, S. Pavone, et al. 2013. Feline cutaneous nerve sheath tumors: Histological features and immunohistochemical evaluations. Res Vet Sci 95(2):548–555.
237 Manfredi, S., A. Volta, M. Fabbi, et al. 2015. What is your diagnosis? Myxosarcoma in a cat. J Am Vet Med Assoc 247(6):597–599.
238 Marcinowska, A., J. Warland, M. Brearley, et al. 2013. A novel approach to treatment of lymphangiosarcoma in a boxer dog. J Small Anim Pract 54(6):334–337.
239 Mayhew, P.D. and D.J. Brockman. 2002. Body cavity lipomas in six dogs. J Small Anim Pract 43(4):177–181.
240 Mayr, B., W. Swidersky, W. Schleger et al. 1990. Cytogenetic characterization of a canine haemangiopericytoma. Br Vet J 146(3):260–263.
241 Mazzei, M., F. Millanta, S. Citi, et al. 2002. Haemangiopericytoma: Histological spectrum, immunohistochemical characterization and prognosis. Vet Dermatol 13(1):15–21.
242 McAbee, K.P., L.L. Ludwig, P.J. Bergman, et al. 2005. Feline cutaneous hemangiosarcoma: A retrospective study of 18 cases (1998–2003). J Am Anim Hosp Assoc 41(2):110–116.
243 McCaw, D.L., M.A. Miller, G.K. Ogilvie, et al. 1994. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 8(6):406–408.
244 Williamson, M.M. and D.J. Middleton. 1998. Cutaneous soft tissue tumors in dogs: Classification, differentiation, and histogenesis. Vet Dermatol 9(1):43–48.
245 McEntee, M.C. 2006. Veterinary radiation therapy: Review and current state of the art. J Am Anim Hosp Assoc 42(2):94–109.
246 McEntee, M.C., R.L. Page, G.N. Mauldin, et al. 2000. Results of irradiation of infiltrative lipoma in 13 dogs. Vet Radiol Ultrasound 41(6):554–556.
247 McEntee, M.C. and V.F. Samii. 2000. The utility of contrast enhanced computed tomography in feline vaccine associated sarcomas: 35 cases [abstract]. Vet Radiol Ultrasound 41:575.
248 McEntee, M.C. and D.E. Thrall. 2001. Computed tomographic imaging of infiltrative lipoma in 22 dogs. Vet Radiol Ultrasound 42(3):221–225.
249 McKnight, J.A., G.N. Mauldin, M.C. McEntee, et al. 2000. Radiation treatment for incompletely resected soft‐tissue sarcomas in dogs. J Am Vet Med Assoc 217(2):205–210.
250 McLaughlin, R. Jr. and A.B. Kuzma. 1991. Intestinal strangulation caused by intra‐abdominal lipomas in a dog. J Am Vet Med Assoc 199(11):1610–1611.
251 McManus, P.M. 1999. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995–1997). J Am Vet Med Assoc 215(3):355–357.
252 McSporran, K. 2009. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas. Vet Pathol 46(5):928–933.
253 Melville, K., K.C. Smith, and M.J. Dobromylskyj. 2015. Feline cutaneous mast cell tumours: A UK‐based study comparing signalment and histological features with long‐term outcomes. J Feline Med Surg 17(6):486–493.
254 Mendez, S.E., K.J. Drobatz, L.E. Duda, et al. 2019. Treating the locoregional lymph nodes with radiation and/or surgery significantly improves outcome in dogs with high‐grade mast cell tumours. Vet Comp Oncol 18(2):239–246.
255 Mesa, K.J., L.E. Selmic, P. Pande, et al. 2017. Intraoperative optical coherence tomography for soft tissue sarcoma differentiation and margin identification. Lasers Surg Med 49(3):240–248.
256 Meuten, D.J. 2016. Tumors in Domestic Animals. Hoboken: John Wiley & Sons.
257 Michels, G.M., D.W. Knapp, D.B. DeNicola, et al. 2002. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor‐free versus nontumor‐free margins: A retrospective study of 31 cases. J Am Anim Hosp Assoc 38(5):458–466.
258 Mikaelian, I. and T.L. Gross. 2002. Keloidal fibromas and fibrosarcomas in the dog. Vet Pathol 39(1):149–153.
259 Miles, J. and D. Clarke. 2001. Intrathoracic lipoma in a Labrador retriever. J Small Anim Pract 42(1):26–28.
260 Millanta, F., P. Asproni, G. Aquino, et al. 2020. Cytologic grading of canine and feline spindle‐cell sarcomas of soft tissues and its correlation with histologic grading. Top Companion Anim Med 41:100458.
261 Miller, M.A., S.L. Nelson, J.R. Turk, et al. 1991. Cutaneous neoplasia in 340 cats. Vet Pathol 28(5):389–395.
262 Miller, A.J., R.G. Cashmore, A.M. Marchevsky, et al. 2016. Negative pressure wound therapy using a portable single‐use device for free skin grafts on the distal extremity in seven dogs. Aust Vet J 94:309–316.
263 Milovancev, M., M. Hauck, C. Keller, et al. 2015. Comparative pathology of canine soft tissue sarcomas: Possible models of human non‐rhabdomyosarcoma soft tissue sarcomas. J Comp Pathol 152(1):22–27.
264 Milovancev, M., K.L. Townsend, E. Gorman, et al. 2017. Shaved margin histopathology and imprint cytology for assessment of excision in canine mast cell tumors and soft tissue sarcomas. Vet Surg 46:879–885.
265 Milovancev, M., K.L. Townsend, S. Bracha, et al. 2018. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs. Vet Surg 47(1):36–43.
266 Mineshige, T., G. Sugahara, T. Ohmuro, et al. 2015. Lymphangiosarcoma with bone formation of the auricle in a dog. J Vet Med Sci 77(6):739–742.
267 Molander‐McCrary, H., C.J. Henry, K. Potter, et al. 1998. Cutaneous mast cell tumors in cats: 32 cases (1991–1994). J Am Anim Hosp Assoc 34(4):281–284.
268 Monteiro, B., S. Boston, G. Monteith. 2011. Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: A retrospective study in 100 dogs. Can Vet J 52:1209–1214.
269 Moore, A.S., A.E. Frimberger, D. Taylor, et al. 2020. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high‐grade, cutaneous mast cell tumours. Vet Comp Oncol 18(3):402–408.
270 Moore, A.S. 2002. Radiation therapy for the treatment of tumors in small companion animals. Vet J 164(3):176–187.
271 Morgan, L.W., R. Toal, G. Siemering, et al. 2007. Imaging diagnosis–infiltrative lipoma causing spinal cord compression in a dog. Vet Radiol Ultrasound 48(1):35–37.
272 Morrison, W.B. and R.M. Starr. 2001. Vaccine‐associated feline sarcomas. J Am Vet Med Assoc 218(5):697–702.
273 Mukaratirwa, S., J. Chipunza, S. Chitanga, et al. 2005. Canine cutaneous neoplasms: Prevalence and influence of age, sex and site on the presence and potential malignancy of cutaneous neoplasms in dogs from Zimbabwe. J S Afr Vet Assoc 76(2):59–62.
274 Mullins, M.N., W.S. Dernell, S.J. Withrow, et al. 2006. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004). J Am Vet Med Assoc 228(1):91–95.
275 Murphy, S., A.H. Sparkes, A.S. Blunden, et al. 2006. Effects of stage and number of tumors on prognosis of dogs with cutaneous mast cell tumors. Vet Rec 158(9):287–291.
276 Murphy, S., A.H. Sparkes, K.C. Smith, et al. 2004. Relationships between the histological grade of cutaneous mast cell tumors in dogs, their survival and the efficacy of surgical resection. Vet Rec 154(24):743–746.
277 Montinaro, V., F. Massari, G. Romanelli. 2015. Use of a coccygeal axial pattern flap for reconstruction following tumour excision in a cat. J Feline Med Surg 17(4):371–374.
278 Nakladal, B., F. vom Hagen, P. Olias, et al. 2012. Intraosseous lipoma in the ulna and radius of a two‐year‐old Leonberger. Vet Comp Orthop Traumatol 25(2):144–148.
279 Nemanic, S., M. Milovancev, J.L. Terry, et al. 2016. Microscopic evaluation of peritumoral lesions of feline injection site sarcomas identified by magnetic resonance imaging and computed tomography. Vet Surg 45(3):392–401.
280 Nolan, M.W., L.R. Griffin, J.T. Custis, et al. 2013. Stereotactic body radiation therapy for treatment of injection‐site sarcomas in cats: 11 cases (2008–2012). J Am Vet Med Assoc 243(4):526–531.
281 Northrup, N.C., E.W. Howerth, B.G. Harmon, et al. 2005. Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. J Vet Diagn Invest 17(6):561–564.
282 Olsen, D., R.C. Straw, S.J. Withrow, et al. 1997. Digital pad transposition for replacement of the metacarpal or metatarsal pad in dogs. J Am Anim Hosp Assoc 33(4):337–341.
283 Ottnod, J.M., R.C. Smedley, R. Walshaw, et al. 2013. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol 11(3):219–229.
284 O’Keefe, D.A., C.G. Couto, C. Burke‐Schwartz, et al. 1987. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1(2):75–80.
285 Owen, L. 1980. TNM Classification of Tumors in Domestic Animals, Geneva: World Health Organization.
286 Pakhrin, B., M.S. Kang, I.H. Bae, et al. 2007. Retrospective study of canine cutaneous tumors in Korea. J Vet Sci 8(3):229–236.
287 Palmieri, C., G. Avallone, M. Cimini, et al. 2013. Use of electron microscopy to classify canine perivascular wall tumors. Vet Pathol 50(2):226–233.
288 Paoletti, E., J. Taylor, B. Meignier, et al. 1995. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. Dev Biol Stand 84:159–163.
289 Parslow, A, D.P. Taylor, and D.J. Simpson. 2016. Clinical, computed tomographic, magnetic resonance imaging, and histologic findings associated with myxomatous neoplasia of the temporomandibular joint in two dogs. J Am Vet Med Assoc 249(11):1301–1307.
290 Patnaik, A.K., W.J. Ehler, and E.G. MacEwen. 1984. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 21(5):469–474.
291 Patterson, C.C., R.L. Perry, and B. Steficek. 2008. Malignant peripheral nerve sheath tumor of the diaphragm in a dog. J Am Anim Hosp Assoc 44(1):36–40.
292 Pavletic, M.M. 2000. Use of an external skin‐stretching device for wound closure in dogs and cats. J Am Vet Med Assoc 217(3):350–354.
293 Pavletic, M.M. 2003. Chapter 23—Pedicle grafts. In Textbook of Small Animal Surgery, 3rd edition. D.H. Slatter, editor. Philadelphia: Saunders.
294 Pavletic, M.M. 2018. Atlas of Small Animal Wound Management and Reconstructive Surgery. Hoboken: John Wiley & Sons.
295 Perry, J.A., W.T. Culp, D.D. Dailey, et al. 2014. Diagnostic accuracy of pre‐treatment biopsy for grading soft tissue sarcomas in dogs. Vet Comp Oncol 12:106–113.
296 Petznek, H., M. Kleiter, A. Tichy, et al. 2014. Murine xenograft model demonstrates significant radio‐sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma. Res Vet Sci 97(2):386–390.
297 Phelps, H.H., C.A. Kuntz, R.J. Milner, et al. 2011. Radical excision with five‐centimeter margins for treatment of feline injection‐site sarcomas: 91 cases (1998–2002). J Am Vet Med Assoc 239(1):97–106.
298 Pierini, A., F. Cinti, D. Binanti, et al. 2017. Primary leiomyosarcoma of the jugular vein in a dog. Open Vet J 7(1):61–64.
299 Pizzoni, S., S. Sabattini, D. Stefanello, et al. 2018. Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study. Vet Comp Oncol 16(1):28–36.
300 Plavec, T., M. Kessler, B. Kandel, et al. 2006. Palliative radiotherapy as treatment for non‐resectable soft tissue sarcomas in the dog – a report of 15 cases. Vet Comp Oncol 4(2):98–103.
301 Poirier, V.J., W.M. Adams, L.J. Forrest, et al. 2006. Radiation therapy for incompletely excised grade II canine mast cell tumors. J Am Anim Hosp Assoc 42(6):430–434.
302 Powers, B.E., P.J. Hoopes, and E.J. Ehrhart. 1995. Tumor diagnosis, grading, and staging. Semin Vet Med Surg (Small Anim) 10(3):158–167.
303 Porcellato, I., C. Brachelente, L. De Paolis, et al. 2019. FoxP3 and IDO in canine melanocytic tumors. Vet Pathol 56:189–199.
304 Pratschke, K.M., M.J. Atherton, J.A. Sillito, et al. 2013. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008–2012). J Am Vet Med Assoc 243(10):1436–1441.
305 Prpich, C.Y., A.C. Santamaria, J.O. Simcock, et al. 2014. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005–2012). J Am Vet Med Assoc 244:187–194.
306 Quintin‐Colonna, F., P. Devauchelle, D. Fradelizi, et al. 1996. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin‐2. Gene Ther 3(12):1104–1112.
307 Ranganathan, B., M. Milovancev, H. Leeper, et al. 2018. Inter‐ and intra‐rater reliability and agreement in determining subcutaneous tumour margins in dogs. Vet Comp Oncol 16(3):392–398.
308 Raposio, E., M. Antonacci, and G. Caruana. 2014. A simple technique for the excision of cutaneous carcinoma: The round block purse‐string suture. World J Surg Oncol 12:263.
309 Rassnick, K.M. 2003. Medical management of soft tissue sarcomas. Vet Clin North Am Small Anim Pract 33(3):517–531.
310 Rassnick, K.M., D.B. Bailey, A.B. Flory, et al. 2008. Efficacy of vinblastine for treatment of canine mast cell tumors. J Vet Intern Med 22(6):1390–1396.
311 Rassnick, K.M., A.S. Moore, L.E. Williams, et al. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13(6):601–605.
312 Rassnick, K.M., D.M. Ruslander, S.M. Cotter, et al. 2001. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 218(9):1444–1448.
313 Rayner, E.L., C.L. Scudamore, I. Francis, et al. 2010. Abdominal fibrosarcoma associated with a retained surgical swab in a dog. J Comp Pathol 143(1):81–85.
314 Reynolds, B.D., M.J. Thomson, K. O'Connell, et al. 2019. Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index. Vet Comp Oncol 17(3):338–344.
315 Risselada, M., K.G. Mathews, and E. Griffith. 2015. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010–2013). J Am Vet Med Assoc 247(2):184–189.
316 Robertson, E.G. and G. Baxter. 2011. Tumor seeding following percutaneous needle biopsy: The real story! Clin Radiol 66:1007–1014.
317 Rohrborn, A. and H.D. Roher. 1998. Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas. Praxis (Bern 1994) 87(34):1050–1060.
318 Romanelli, G., L. Marconato, D. Olivero, et al. 2008. Analysis of prognostic factors associated with injection‐site sarcomas in cats: 57 cases (2001–2007). J Am Vet Med Assoc 232(8):1193–1199.
319 Romansik, E.M., C.M. Reilly, P.H. Kass, et al. 2007. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44(3):335–341.
320 Rousset, N., M.A. Holmes, A. Caine, et al. 2013. Clinical and low‐field MRI characteristics of injection site sarcoma in 19 cats. Vet Radiol Ultrasound 54(6):623–629.
321 Rossi, F., M. Korner, J. Suarez, et al. 2018. Computed tomographic‐lymphography as a complementary technique for lymph node staging in dogs with malignant tumors of various sites. Vet Radiol Ultrasound 59(2):155–162.
322 Sabattini, S., M. Giantin, A. Barbanera, et al. 2016. Feline intestinal mast cell tumours: Clinicopathological characterisation and KIT mutation analysis. J Feline Med Surg 18:280–289.
323 Sabattini, S. and G. Bettini. 2019. Grading cutaneous mast cell tumors in cats. Vet Pathol 56(1):43–49.
324 Sabattini, S., A. Renzi, L. Marconato, et al. 2018. Comparison between May‐Grunwald‐Giemsa and rapid cytological stains in fine‐needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications. Vet Comp Oncol 16(4):511–517.
325 Salgüero, R., J. Demetriou, F. Constantino‐Casas, et al. 2015. Hypertrophic osteopathy in a cat with a concurrent injection‐site sarcoma. JFMS Open Rep 1(2) https://doi.org/10.1177%2F2055116915593968.
326 Sanchez, A., A. Valverde, M. Sinclair, et al. 2017. Antihistaminic and cardiorespiratory effects of diphenhydramine hydrochloride in anesthetized dogs undergoing excision of mast cell tumors. J Am Vet Med Assoc 251(7):804–813.
327 Saunders, H., M.J. Thomson, K. O’Connell, et al. 2020. Evaluation of a modified proportional margin approach for complete surgical excision of canine cutaneous mast cell tumours and its associated clinical outcome. Vet Comp Oncol doi:10.1111/vco.12630. Online ahead of print.
328 Sawamoto, O., J. Yamate, M. Kuwamura, et al. 1999. A canine peripheral nerve sheath tumor including peripheral nerve fibers. J Vet Med Sci 61(12):1335–1338.
329 Scarpa, F., S. Sabattini, and G. Bettini. 2016. Cytological grading of canine cutaneous mast cell tumours. Vet Comp Oncol 14(3):245–251.
330 Scase, T.J., D. Edwards, J. Miller, et al. 2006. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20(1):151–158.
331 Scavelli, T.D., A.K. Patnaik, C.J. Mehlhaff, et al. 1985. Hemangiosarcoma in the cat: Retrospective evaluation of 31 surgical cases. J Am Vet Med Assoc 187(8):817–819.
332 Schlieman, M., R. Smith, and W.G. Kraybill. 2006. Adjuvant therapy for extremity sarcomas. Curr Treat Options Oncol 7(6):456– 463.
333 Schulman, F.Y., T.O. Johnson, P.R. Facemire, et al. 2009. Feline peripheral nerve sheath tumors: Histologic, immunohistochemical, and clinicopathologic correlation (59 tumors in 53 cats). Vet Pathol 46(6):1166–1180.
334 Schultheiss, P.C. 2004. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16(6):522–526.
335 Schultheiss, P.C., D.W. Gardiner, S. Rao, et al. 2011. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 238(11):1464–1469.
336 Schwab, T.M., C. Popovitch, J. DeBiasio, et al. 2014. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004–2008). J Am Anim Hosp Assoc 50(3):187–191.
337 Séguin, B., M.F. Besancon, J.L. McCallan, et al. 2006. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994–2002). J Vet Intern Med 20(4):933–940.
338 Séguin, B., N.F. Leibman, V.S. Bregazzi, et al. 2001. Clinical outcome of dogs with grade‐II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc 218(7):1120–1123.
339 Séguin, B., D.E. McDonald, M.S. Kent, et al. 2005. Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Vet Surg 34(3):214–222.
340 Selmic, L.E., J. Samuelson, J.K. Reagan, et al. 2019. Intra‐operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography. Vet Comp Oncol 17:80–88.
341 Selting, K.A., B.E. Powers, L.J. Thompson, et al. 2005. Outcome of dogs with high‐grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996–2004). J Am Vet Med Assoc 227(9):1442–1448.
342 Sfiligoi, G., K.M. Rassnick, J.M. Scarlett, et al. 2005. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990–2001). J Am Vet Med Assoc 226(8):1368–1374.
343 Shaw, S.C., M.S. Kent, I.K. Gordon, et al. 2009. Temporal changes in characteristics of injection‐site sarcomas in cats: 392 cases (1990–2006). J Am Vet Med Assoc 234(3):376–380.
344 Shaw, T., S.T. Kudnig, and S.M. Firestone. 2018. Diagnostic accuracy of pre‐treatment biopsy for grading cutaneous mast cell tumours in dogs. Vet Comp Oncol 16(2):214–219.
345 Shelly, S.M. 2003. Cutaneous lesions. Vet Clin North Am Small Anim Pract 33(1):1–46.
346 Shin, H., A. Nam, K.H. Song, et al. 2018. Anticancer effects of high‐dose ascorbate on canine melanoma cell lines. Vet Comp Oncol 16(4):616–621.
347 Shoop, S.J., S. Marlow, D.B. Church, et al. 2015. Prevalence and risk factors for mast cell tumours in dogs in England. Canine Genet Epidemiol 2:1.
348 Sicotte, V., J. Benamou, L.C. Fifle, et al. 2012. Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma. J Am Vet Med Assoc 241(12):1639–1644.
349 Silva, E.O., P.F.I. Goiozo, L.G. Pereira, et al. 2017. Concomitant malignant pulmonary peripheral nerve sheath tumour and benign cutaneous peripheral nerve sheath tumour in a dog. J Comp Pathol 157(1):46–50.
350 Simon, D., D.M. Ruslander, K.M. Rassnick, et al. 2007. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft‐tissue sarcomas in 39 dogs. Vet Rec 160(10):321–326.
351 Simpson, A.M., L.L. Ludwig, S.J. Newman, et al. 2004. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 224(2):236–240.
352 Smiech, A., B. Slaska, W. Lopuszynski, et al. 2018. Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two‐grade malignancy classification. Acta Vet Scand 60(1):70.
353 Smith, J., M. Kiupel, J. Farrelly, et al. 2017. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone. Vet Comp Oncol 15(1):36–45.
354 Sorenmo, K.U., K.A. Jeglum, and S.C. Helfand. 1993. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 7(6):370–376.
355 Spoldi, E., T. Schwarz, S. Sabattini, et al. 2017. Comparisons among computed tomographic features of adipose masses in dogs and cats. Vet Radiol Ultrasound 58(1):29–37.
356 Spugnini, E.P., B. Vincenzi, G. Citro, et al. 2007a. Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas. InVivo 21(5):819–822.
357 Spugnini, E.P., A. Baldi, B. Vincenzi, et al. 2007b. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: A preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 59(3):375–381.
358 Spugnini, E.P., S.M. Renaud, S. Buglioni, et al. 2011. Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: An approach to improve the therapeutic index of highly toxic chemotherapy drugs. J Transl Med 14(9):152.
359 Spugnini, E.P., B. Vincenzi. B. Amadio, et al. 2019. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases. Open Vet J 9(1):88–93.
360 Spugnini, E.P., B. Vincenzi, F. F. Carocci, et al. 2020. Combination of bleomycin and cisplatin as adjuvant electrochemotherapy protocol for the treatment of incompletely excised feline injection‐site sarcomas: A retrospective study. Vet J 10(3):267–271.
361 Stanclift, R.M. and S.D. Gilson. 2008. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 232(1):53–62.
362 Stanley, B.J., K.A. Pitt, C.D. Weder, et al. 2013. Effects of negative pressure wound therapy on healing of free full‐thickness skin grafts in dogs. Vet Surg 42:511–522.
363 Stefanello, D., E. Morello, P. Roccabianca, et al. 2008. Marginal excision of low‐grade spindle cell sarcoma of canine extremities: 35 dogs (1996–2006). Vet Surg 37(5):461–465.
364 Stefanello D., G. Avallone, R. Ferrari, et al. 2011. Canine cutaneous perivascular wall tumors at first presentation: Clinical behavior and prognostic factors in 55 cases. J Vet Intern Med 25(6):1398–1405.
365 Stefanello, D., P. Valenti, S. Faverzani, et al. 2009. Ultrasound‐guided cytology of spleen and liver: A prognostic tool in canine cutaneous mast cell tumor. J Vet Intern Med 23(5):1051–1057.
366 Stefanello, D., P. Buracco, S. Sabattini, et al. 2015. Comparison of 2‐and 3‐category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014). J Am Vet Med Assoc 246(7):765–769.
367 Straw, R.C., S.J. Withrow, and B.E. Powers. 1992. Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 21(3):183–188.
368 Sugiyama, A., T. Morita, A. Shimada, et al. 2008. Primary malignant peripheral nerve sheath tumor with eosinophilic cytoplasmic globules arising from the greater omentum in a dog. J Vet Med Sci 70(7):739–742.
369 Suzuki, S., K. Uchida, and H. Nakayama. 2014. The effects of tumor location on diagnostic criteria for canine malignant peripheral nerve sheath tumors (MPNSTs) and the markers for distinction between canine MPNSTs and canine perivascular wall tumors. Vet Pathol 51(4):722–736.
370 Swaim, S.F. 2003. Chapter 24—Skin grafts. In Textbook of Small Animal Surgery, 3rd edition. D.H. Slatter, editor. Philadelphia: Saunders.
371 Szivek, A., R.E. Burns, B. Gericota, et al. 2012. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993–2007. Vet Comp Oncol 10(1):65–73.
372 Teixeira, S., I. Amorim, A. Rêma, et al. 2016. Molecular heterogeneity of canine cutaneous peripheral nerve sheath tumors: A drawback in the diagnosis refinement. In Vivo 30(6):819–827.
373 Terry, J.L., M. Milovancev, C.V. Löhr, et al. 2016. Changes in the dimension and volume of feline injection‐site sarcomas following formalin fixation as determined by use of the ellipsoid volume formula and three‐dimensional computed tomography software. Am J Vet Res 77(6):620–626.
374 Terry, J.L., M. Milovancev, S. Nemanic, et al. 2017. Quantification of surgical margin length changes after excision of feline injection site sarcomas‐A pilot study. Vet Surg 46(2):189–196.
375 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor – 41 cases (1992–1997). J Vet Intern Med 13(5):491–497.
376 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumor: 61 cases. J Vet Med Sci 68(6):581–587.
377 Theilen, G.H. and B.R. Madewell. 1979. Veterinary Cancer Medicine. Philadelphia: Lea & Febiger.
378 Thompson, J.J., D.L. Pearl, J.A. Yager, et al. 2011. Canine subcutaneous mast cell tumor: Characterization and prognostic indices. Vet Pathol 48(1):156–168.
379 Thongtharb, A., J.K. Chambers, K. Uchida et al. 2015. Lymphangiosarcoma with systemic metastases in a Japanese domestic cat. J Vet Med Sci 77(3):371–374.
380 Thornton, K. 2008. Chemotherapeutic management of soft tissue sarcoma. Surg Clin North Am 88(3):647–660, viii.
381 Torrigiani, F., A. Pierini, R. Lowe, et al. 2019. Soft tissue sarcoma in dogs: A treatment review and a novel approach using electrochemotherapy in a case series. Vet Comp Oncol 17:234–241.
382 Trappler, M.C., C.A. Popovitch, M.H. Goldschmidt, et al. 2014. Scrotal tumors in dogs: A retrospective study of 676 cases (1986–2010). Can Vet J 55(1):1229–1233.
383 Trout, N.J., M.M. Pavletic, and K.H. Kraus. 1995. Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 207(5):585–587.
384 Tsioli, V., L.G. Papazoglou, N. Papaioannou, et al. 2015. Comparison of three skin‐stretching devices for closing skin defects on the limbs of dogs. J Vet Sci 16:99–106.
385 Tsuji, N., S. Furukawa, and K. Ozaki. 2013. Cutaneous hemangiosarcoma in a dog. J Toxicol Pathol 26(2):193–195.
386 Tuohy, J.L., J. Milgram, D.R. Worley, et al. 2009. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Vet Comp Oncol7(2):81–91.
387 Turek, M., R. Gogal Jr, C. Saba, et al. 2014. Masitinib mesylate does not enhance sensitivity to radiation in three feline injection‐site sarcoma cell lines under normal growth conditions. Res Vet Sci 96(2):304–307.
388 Turrel, J.M., J. Farrelly, R.L. Page, et al. 2006. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992–2002). J Am Vet Med Assoc 228(6):898–901.
389 Turrel, J.M., B.E. Kitchell, L.M. Miller, et al. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 193(8):936–940.
390 Upchurch, D.A., E.E. Klocke, and J.N. Henningson. 2018. Amount of skin shrinkage affecting tumor versus grossly normal marginal skin of dogs for cutaneous mast cell tumors excised with curative intent. Am J Vet Res 79(7):779–786.
391 Vail, D.M. and S.J. Withrow. 2007. Tumors of the skin and subcutaneous tissues. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition, pp. 375–401. S.J. Withrow and E.G. MacEwen, editors. St. Louis: Saunders Elsevier.
392 Vail, D., D. Thamm, and J. Liptak. 2019. Withrow and MacEwen’s Small Animal Clinical Oncology. St. Louis: Saunders.
Vet J
1 Vascellari, M., E. Melchiotti, E. Bozza et al. 2003. Fibrosarcomas at presumed sites of injection in dogs: Characteristics and comparison with non‐vaccination site sarcomas and feline post‐vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 50(6):286–291.
2 Vascellari, M., E. Melchiotti, and F. Mutinelli. 2006. Fibrosarcoma with typical features of postinjection sarcoma at site of microchip implant in a dog: Histologic and immunohistochemical study. Vet Pathol 43(4):545–548.
3 Verganti, S., D. Berlato, L. Blackwood, et al. 2017. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK. J Small Anim Pract 58(1):10–16.
4 Vickery, K.R., H. Wilson, D.M. Vail, et al. 2008. Dose‐escalating vinblastine for the treatment of canine mast cell tumor. Vet Comp Oncol 6(2):111–119.
5 Villamil, J.A., C.J. Henry, and J.N. Bryan. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.
6 Villamill, J.A., C.J.Henry, J.N. Bryan, et al. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.
7 Villedieu, E.J., A.F. Petite, J.D. Godolphin, et al. 2021. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma. J Am Vet Med Assoc 258:179–185.
8 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8(5):345–348.
9 Warland, J., I. Amores‐Fuster, W. Newbury, et al. 2014. The utility of staging in canine mast cell tumours. Vet Comp Oncol 12(4):287–298.
10 Weishaar, K.M., D.H. Thamm, D.R. Worley, et al. 2014. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. J Comp Pathol 151(4):329–338.
11 Weishaar, K.M., E.J. Ehrhart, A.C. Avery, et al. 2018. c‐Kit mutation and localization status as response predictors in mast cell tumors in dogs treated with prednisone and toceranib or vinblastine. J Vet Intern Med 32(1):394–405.
12 Weisse, C., F.S. Shofer, and K. Sorenmo. 2002. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38(1):71–73.
13 Williams, J.H. 2005. Lymphangiosarcoma of dogs: A review. J S Afr Vet Assoc 76(3):127–131.
14 Worley, D.R. 2014. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Vet Comp Oncol 12(3):215–226.
15 Zardo, K.M., L.P. Damiani, J.M. Matera, et al. 2016. Recurrent and non‐recurrent feline injection‐site sarcoma: Computed tomographic and ultrasonographic findings. J Feline Med Surg 18(10):773–782.
